24 February 2019 - President Donald J. Trump has made it a promise to lower drug prices for all Americans. As a populist, he has hit on a very important issue, because ultimately the manufacturers of drugs own a large percentage of responsibility for high drug prices.

There are a number of reasons why we have high health care costs for services and drugs, including the massive amount of money that the government has sunk into health care and the fact that drugs are one product where consumers seldom know the actual end cost of a drug.

Congress is studying ways to lower drug prices right now. The Senate Finance Committee is holding a hearing on Feb. 26, 2019, titled “Drug Pricing in America: A Prescription for Change, Part II.” This is a follow up to a hearing where testimony was provided that points a finger at the drug companies for high drug prices. Mark Miller, the executive vice president of health care at the Laura and John Arnold Foundation, testified that high drug prices are expected to go even higher in the coming years.

Read Washington Times article